Structural basis of oncogenic histone H3K27M inhibition of human polycomb repressive complex 2-Reference-Cited by-同舟云学术

Structural basis of oncogenic histone H3K27M inhibition of human polycomb repressive complex 2

Published:2016-04-28 Issue:1 Volume:7 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Justin Neil,Zhang Ying,Tarricone Cataldo,Martin Stephen R.,Chen Shuyang,Underwood Elizabeth,De Marco Valeria,Haire Lesley F.,Walker Philip A.,Reinberg Danny,Wilson Jon R.,Gamblin Steven J.

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms11316.pdf

Reference38 articles.

1. Shilatifard, A. Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. Annu. Rev. Biochem. 75, 243–269 (2006).

2. Simon, J. A. & Kingston, R. E. Mechanisms of polycomb gene silencing: knowns and unknowns. Nat. Rev. Mol. Cell Biol. 10, 697–708 (2009).

3. Laugesen, A. & Helin, K. Chromatin repressive complexes in stem cells, development and cancer. Cell Stem Cell 14, 735–751 (2014).

4. Berger, S. L. The complex language of chromatin regulation during transcription. Nature 447, 407–412 (2007).

5. Margueron, R. et al. Role of the polycomb protein EED in the propagation of repressive histone marks. Nature 461, 762–767 (2009).

Cited by 333 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. H3K27M diffuse midline glioma is homologous recombination defective and sensitized to radiotherapy and NK cell-mediated antitumor immunity by PARP inhibition;2024-08-27

2. Navigating the complexity of Polycomb repression: Enzymatic cores and regulatory modules;Molecular Cell;2024-08

3. Replication-coupled inheritance of chromatin states;Cell Insight;2024-08

4. Targeting EED as a key PRC2 complex mediator toward novel epigenetic therapeutics;Drug Discovery Today;2024-06

5. Pediatric Diffuse Midline Glioma H3K27-Altered: From Developmental Origins to Therapeutic Challenges;Cancers;2024-05-10